Wilhelmus C. M. Groenhuysen's most recent trade in OptiNose Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 3,566 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 2,133 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 1,925 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 962 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 962 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 962 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 962 | 0 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 12.24 per share. | 28 Jun 2024 | 1,055 | 252,290 (0%) | 0% | 12.2 | 12,913 | Ordinary Shares |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 124,373 | 95,000 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.82 per share. | 05 Jun 2024 | 124,373 | 124,373 (0%) | 0% | 22.8 | 2,838,192 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 01 Mar 2024 | 2,107 | 252,452 (0%) | 0% | 16.0 | 33,769 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 01 Mar 2024 | 1,217 | 251,235 (0%) | 0% | 16.0 | 19,484 | Ordinary Shares |
| NovoCure Ltd | Groenhuysen C. M. Wilhelmus | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 71,920 | 71,920 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | C. M. Wilhelmus Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 16.30 per share. | 27 Feb 2024 | 47,034 | 256,862 (0%) | 0% | 16.3 | 766,654 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.14 per share. | 27 Feb 2024 | 2,303 | 254,559 (0%) | 0% | 16.1 | 37,177 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus Groenhuysen C. M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 12.67 per share. | 27 Feb 2024 | 3 | 209,828 (0%) | 0% | 12.7 | 38 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.82 per share. | 01 Sep 2023 | 294 | 209,825 (0%) | 0% | 21.8 | 6,414 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 366 | 210,119 (0%) | 0% | 35.3 | 12,912 | Ordinary Shares |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 53,500 | 53,500 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 20,415 | 209,753 (0%) | 0% | 76.2 | 1,554,794 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 3,528 | 231,860 (0%) | 0% | 76.2 | 268,690 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 1,692 | 230,168 (0%) | 0% | 76.2 | 128,862 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 48,050 | 231,452 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 3,936 | 235,388 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 02 Mar 2023 | 1,213 | 183,402 (0%) | 0% | 75.3 | 91,312 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 36,013 | 36,013 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 21,653 | 186,779 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.36 per share. | 28 Feb 2023 | 2,164 | 184,615 (0%) | 0% | 76.4 | 165,248 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 62.30 per share. | 06 Jan 2023 | 102 | 165,126 (0%) | 0% | 62.3 | 6,355 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.04 per share. | 02 Sep 2022 | 296 | 165,024 (0%) | 0% | 79.0 | 23,395 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 59.07 per share. | 05 Jul 2022 | 218 | 165,320 (0%) | 0% | 59.1 | 12,878 | Ordinary Shares |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2022 | 1,324 | 147,048 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2022 | 1,324 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.10 per share. | 08 Mar 2022 | 2,923 | 165,102 (0%) | 0% | 70.1 | 204,902 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 38,390 | 38,390 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 21,921 | 171,895 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,664 | 7,664 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.41 per share. | 03 Mar 2022 | 2,569 | 168,025 (0%) | 0% | 70.4 | 180,876 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 03 Mar 2022 | 1,301 | 170,594 (0%) | 0% | 74.5 | 96,922 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 63.81 per share. | 06 Jan 2022 | 75 | 149,974 (0%) | 0% | 63.8 | 4,786 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 138.23 per share. | 02 Sep 2021 | 181 | 149,899 (0%) | 0% | 138.2 | 25,020 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2021 | 320 | 145,724 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2021 | 320 | 1,324 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 137.12 per share. | 06 Jul 2021 | 66 | 150,080 (0%) | 0% | 137.1 | 9,050 | Ordinary Shares |
| OptiNose Inc | Wilhelmus C. M. Groenhuysen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 14,439 | 14,439 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 130.81 per share. | 08 Mar 2021 | 3,004 | 153,684 | - | 130.8 | 392,941 | Restricted Share Units |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 137.55 per share. | 04 Mar 2021 | 3,854 | 156,688 | - | 137.6 | 530,133 | Restricted Share Units |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 23,004 | 23,004 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 12,519 | 160,542 | - | 0 | Restricted Share Units | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 152.05 per share. | 02 Mar 2021 | 2,392 | 148,023 | - | 152.1 | 363,711 | Restricted Share Units |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 7,715 | 0 | - | - | Restricted Stock Units | |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 149.10 per share. | 27 Feb 2021 | 7,715 | 150,415 (0%) | 0% | 149.1 | 1,150,307 | Ordinary Shares |
| NovoCure Ltd | Wilhelmus C. M. Groenhuysen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 50.67 per share. | 06 Jan 2021 | 93 | 142,700 (0%) | 0% | 50.7 | 4,712 | Ordinary Shares |